
226: Pharma's telehealth gold mine, the return of the biotech IPO, & a merger deferred
The Readout Loud
00:00
Seagen's Stock Price Slipped Below $140 for the First Time in a Month
Seagen's stock price slipped below where it was trading on June 17th, which is when the Wall Street Journal first reported that Merck was interested in buying the company. Seagen traded at around $180, $185. Now at what is apparently the low point, it's down to $140. I don't know if people have given up entirely on the notion of this deal being done.
Transcript
Play full episode